D5 Logo (Tradjenta 5 mg)

Generic Name: linagliptin

Pill imprint D5 Logo has been identified as Tradjenta 5 mg.

Tradjenta is used in the treatment of diabetes, type 2 and belongs to the drug class dipeptidyl peptidase 4 inhibitors. There is no proven risk in humans during pregnancy. Tradjenta 5 mg is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for D5 Logo

Tradjenta 5 mg D5 Logo
Tradjenta 5 mg D5 Logo
Tradjenta
Generic Name:
linagliptin
Imprint:
D5
Logo
Strength:
5 mg
Color:
Red
Shape:
Round
Availability:
Prescription only
Drug Class:
Dipeptidyl peptidase 4 inhibitors
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Boehringer Ingelheim Pharmaceuticals, Inc.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)